Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

NCT00098293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

916

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: Maraviroc + Zidovudine/Lamivudine
DRUG: Efavirenz + Zidovudine/Lamivudine
DRUG: Maraviroc (UK-427,857) + Zidovudine/Lamivudine

Sponsor

ViiV Healthcare

Collaborators

[object Object]